NLRP3 inflammasome blockade inhibits VEGF-A-induced age-related macular degeneration

Cell Reports

Volumn 4, Issue 5, 2013, Pages 945-958

  Marneros, AlexanderG ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CRYOPYRIN; CYTOKINE; INFLAMMASOME; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; PHALLOIDIN; VASCULOTROPIN A;

3' UNTRANSLATED REGION; ARTICLE; GENE LOCUS; MOUSE; NONHUMAN; PATHOGENESIS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN TARGETING; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; WOUND HEALING;

AGE FACTORS; ANIMALS; CARRIER PROTEINS; HUMANS; INFLAMMASOMES; MACULAR DEGENERATION; MICE; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84884147872     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.08.002     Document Type: Article

References (40)

1. Ablonczy Z., Dahrouj M., Tang P.H., Liu Y., Sambamurti K., Marmorstein A.D., Crosson C.E. Human retinal pigment epithelium cells as functional models for the RPE invivo. Invest. Ophthalmol. Vis. Sci. 2011, 52:8614-8620.
2. Anderson D.H., Mullins R.F., Hageman G.S., Johnson L.V. A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol. 2002, 134:411-431.
3. Bird A.C., Bressler N.M., Bressler S.B., Chisholm I.H., Coscas G., Davis M.D., de Jong P.T., Klaver C.C., Klein B.E., Klein R., et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv. Ophthalmol. 1995, 39:367-374. The International ARM Epidemiological Study Group.
4. Brydges S.D., Mueller J.L., McGeough M.D., Pena C.A., Misaghi A., Gandhi C., Putnam C.D., Boyle D.L., Firestein G.S., Horner A.A., et al. Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. Immunity 2009, 30:875-887.
5. Cao X., Shen D., Patel M.M., Tuo J., Johnson T.M., Olsen T.W., Chan C.C. Macrophage polarization in the maculae of age-related macular degeneration: a pilot study. Pathol. Int. 2011, 61:528-535.
6. Cervi D., Shaked Y., Haeri M., Usenko T., Lee C.R., Haigh J.J., Nagy A., Kerbel R.S., Yefenof E., Ben-David Y. Enhanced natural-killer cell and erythropoietic activities in VEGF-A-overexpressing mice delay F-MuLV-induced erythroleukemia. Blood 2007, 109:2139-2146.
7. Curcio C.A., Presley J.B., Malek G., Medeiros N.E., Avery D.V., Kruth H.S. Esterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathy. Exp. Eye Res. 2005, 81:731-741.
8. Curcio C.A., Presley J.B., Millican C.L., Medeiros N.E. Basal deposits and drusen in eyes with age-related maculopathy: evidence for solid lipid particles. Exp. Eye Res. 2005, 80:761-775.
9. Damert A., Miquerol L., Gertsenstein M., Risau W., Nagy A. Insufficient VEGFA activity in yolk sac endoderm compromises haematopoietic and endothelial differentiation. Development 2002, 129:1881-1892.
10. Dorrell M.I., Aguilar E., Jacobson R., Yanes O., Gariano R., Heckenlively J., Banin E., Ramirez G.A., Gasmi M., Bird A., et al. Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress. J.Clin. Invest. 2009, 119:611-623.
11. Doyle S.L., Campbell M., Ozaki E., Salomon R.G., Mori A., Kenna P.F., Farrar G.J., Kiang A.S., Humphries M.M., Lavelle E.C., et al. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat. Med. 2012, 18:791-798.
12. Duewell P., Kono H., Rayner K.J., Sirois C.M., Vladimer G., Bauernfeind F.G., Abela G.S., Franchi L., Nuñez G., Schnurr M., et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464:1357-1361.
13. Friedman D.S., O'Colmain B.J., Muñoz B., Tomany S.C., McCarty C., de Jong P.T., Nemesure B., Mitchell P., Kempen J. Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 2004, 122:564-572. Eye Diseases Prevalence Research Group.
14. Fritsche L.G., Chen W., Schu M., Yaspan B.L., Yu Y., Thorleifsson G., Zack D.J., Arakawa S., Cipriani V., Ripke S., et al. Seven new loci associated with age-related macular degeneration. Nat. Genet. 2013, 45:433-439. AMD Gene Consortium, e1-e2.
15. Funk M., Karl D., Georgopoulos M., Benesch T., Sacu S., Polak K., Zlabinger G.J., Schmidt-Erfurth U. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. Ophthalmology 2009, 116:2393-2399.
16. Glaccum M.B., Stocking K.L., Charrier K., Smith J.L., Willis C.R., Maliszewski C., Livingston D.J., Peschon J.J., Morrissey P.J. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J.Immunol. 1997, 159:3364-3371.
17. He L., Marneros A.G. Macrophages are essential for the early wound healing response and the formation of a fibrovascular scar. Am. J. Pathol. 2013, 182:2407-2417.
18. Imamura Y., Noda S., Hashizume K., Shinoda K., Yamaguchi M., Uchiyama S., Shimizu T., Mizushima Y., Shirasawa T., Tsubota K. Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc. Natl. Acad. Sci. USA 2006, 103:11282-11287.
19. Jafarifar F., Yao P., Eswarappa S.M., Fox P.L. Repression of VEGFA by CA-rich element-binding microRNAs is modulated by hnRNP L. EMBO J. 2011, 30:1324-1334.
20. Kaneko H., Dridi S., Tarallo V., Gelfand B.D., Fowler B.J., Cho W.G., Kleinman M.E., Ponicsan S.L., Hauswirth W.W., Chiodo V.A., et al. DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature 2011, 471:325-330.
21. Kauppinen A., Niskanen H., Suuronen T., Kinnunen K., Salminen A., Kaarniranta K. Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells-implications for age-related macular degeneration (AMD). Immunol. Lett. 2012, 147:29-33.
22. Klein R., Peto T., Bird A., Vannewkirk M.R. The epidemiology of age-related macular degeneration. Am. J. Ophthalmol. 2004, 137:486-495.
23. Klettner A., Roider J. Constitutive and oxidative-stress-induced expression of VEGF in the RPE are differently regulated by different Mitogen-activated protein kinases. Graefes Arch. Clin. Exp. Ophthalmol. 2009, 247:1487-1492.
24. Kliffen M., van der Schaft T.L., Mooy C.M., de Jong P.T. Morphologic changes in age-related maculopathy. Microsc. Res. Tech. 1997, 36:106-122.
25. Latz E., Xiao T.S., Stutz A. Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 2013, 13:397-411.
26. Marneros A.G., Fan J., Yokoyama Y., Gerber H.P., Ferrara N., Crouch R.K., Olsen B.R. Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am. J. Pathol. 2005, 167:1451-1459.
27. Martin D.F., Maguire M.G., Ying G.S., Grunwald J.E., Fine S.L., Jaffe G.J. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N.Engl. J. Med. 2011, 364:1897-1908. CATT Research Group.
28. Miquerol L., Gertsenstein M., Harpal K., Rossant J., Nagy A. Multiple developmental roles of VEGF suggested by a LacZ-tagged allele. Dev. Biol. 1999, 212:307-322.
29. Monaghan-Benson E., Burridge K. The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species. J.Biol. Chem. 2009, 284:25602-25611.
30. Oh H., Takagi H., Takagi C., Suzuma K., Otani A., Ishida K., Matsumura M., Ogura Y., Honda Y. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest. Ophthalmol. Vis. Sci. 1999, 40:1891-1898.
31. Sunness J.S., Gonzalez-Baron J., Bressler N.M., Hawkins B., Applegate C.A. The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration. Ophthalmology 1999, 106:910-919.
32. Takeda K., Tsutsui H., Yoshimoto T., Adachi O., Yoshida N., Kishimoto T., Okamura H., Nakanishi K., Akira S. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998, 8:383-390.
33. Tarallo V., Hirano Y., Gelfand B.D., Dridi S., Kerur N., Kim Y., Cho W.G., Kaneko H., Fowler B.J., Bogdanovich S., et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 2012, 149:847-859.
34. Tseng W.A., Thein T., Kinnunen K., Lashkari K., Gregory M.S., D'Amore P.A., Ksander B.R. NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2013, 54:110-120.
35. van Leeuwen R., Klaver C.C., Vingerling J.R., Hofman A., de Jong P.T. Epidemiology of age-related maculopathy: a review. Eur. J. Epidemiol. 2003, 18:845-854.
36. Wen H., Gris D., Lei Y., Jha S., Zhang L., Huang M.T., Brickey W.J., Ting J.P. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 2011, 12:408-415.
37. Wen H., Ting J.P., O'Neill L.A. A role for the NLRP3 inflammasome in metabolic diseases-did Warburg miss inflammation?. Nat. Immunol. 2012, 13:352-357.
38. Wilkie A.L., Jordan S.A., Jackson I.J. Neural crest progenitors of the melanocyte lineage: coat colour patterns revisited. Development 2002, 129:3349-3357.
39. Wu K.H., Madigan M.C., Billson F.A., Penfold P.L. Differential expression of GFAP in early v late AMD: a quantitative analysis. Br. J. Ophthalmol. 2003, 87:1159-1166.
40. Yu Y., Bhangale T.R., Fagerness J., Ripke S., Thorleifsson G., Tan P.L., Souied E.H., Richardson A.J., Merriam J.E., Buitendijk G.H., et al. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum. Mol. Genet. 2011, 20:3699-3709.